BioAro Inc.

BioAro Inc., a Calgary-based precision health leader, develops AI-driven mobile platforms using facial recognition and wearable sensors to collect blood pressure, ECG, heart rate, HRV, oxygen saturation, and mental health data—targeting degenerative brain diseases and dementia. This data integrates with multi-omics (genomic, epigenomic, transcriptomic, microbiome, pharmacogenomic) via PanOmiQ and BioEMR for predictive, personalized care. Real-time decision support empowers clinics, insurers, and patients with early detection, optimized treatments, and longevity solutions.

It has two Point of Care Diagnostic devices on the market (FDA & Health Canada approved) which include a 24/7 Ambulatory Blood Presure and ECG Monitoring (Holter) devices. A next generation cuffles Blood pressure, ECG, Heart Rate and Oxygen saturation measuring device is currently undergoing clinical trials.

The company has developed Microfluidic and Lateral flow based POCD for blood, urine and saliva makers for chronic, infectious and airborne diseases which can be used as POC devices, in remote areas and by Astronauts during space flights and in Habitats created to simulate, extra-terresterial conditions.

All data is protected using Blockchain driven auditable protections systems. The analysis software platforms use classical computing, however, transition into Quantum based platforms, is underway.